Women with high co-pays prone to stop cancer drug
NEW YORK (Reuters Health) - Women taking breast cancer drugs are more likely to skip days or drop the treatment entirely if their co-pay is high, U.S. researchers have found.
It's nothing new that people often don't take the medication their doctor prescribes, but for cancer drugs the consequences could be dire, experts say.
"Here we are talking about a life-saving drug," said Dr. Alfred Neugut of Columbia University Medical Center in New York, whose findings appear in the Journal of Clinical Oncology.
"For drugs that are that important, maybe we need to set up mechanisms to provide ways to get around the co-pays or deductibles."
Some insurance companies already have programs in place to ensure lower co-pays for certain drugs, Neugut said, but they don't cover aromatase inhibitors, the focus of the new study.
Such drugs, including AstraZeneca's Arimidex, significantly lower the risk of death in breast cancer survivors who've gone through menopause.
While Arimidex can now be bought as a generic drug for only less than a dollar per pill, the drug cost more than $2,000 a year when the study was done.
Neugut and his colleagues used claims data from MedCo Health Solutions to find out what role patient co-pay might play in whether or not they took their drugs for the recommended five years.
Of more than 8,000 women aged 50 to 65, 20 percent stopped the medication early if their co-pay was less than $30.
By contrast, if the co-pay was $90 or more, 23 percent dropped the drugs ahead of time.
For older women, the gap was five nearly percent, which Neugut chalks up to less disposable income.
There were similar differences in the number of women who skipped at least 20 percent of days, and the gap remained even after the researchers considered possible explanations such as income and other factors.
"If the co-pay gets too high, it is going to stop people from taking a drug they really need," said Neugut, adding that earlier research has noted the same effect for prescriptions as a whole.
With the healthcare reform, more people are expected to be covered by Medicaid, which generally means they will have lower co-pay. Yet Neugut said it's unclear what effect that will have, given Medicaid beneficiaries have fewer resources to begin with.
He said the problem was more serious for cancer drugs than for other medicines, because the former treat a potential deadly disease.
In addition, cancer drugs have side effects, which may also deter women from taking them.
In general, Neugut told Reuters Health, "Less than 50 percent of women actually finish the five years -- and if you don't, you lose most or all of the survival benefit from the therapy."
SOURCE: http://bit.ly/ilztyr Journal of Clinical Oncology, May 25, 2011.
Sign Up for Free Newsletters
Ask Your Doctor the RIGHT Questions!
the most from your doctor visit.
Emailed right to you!
The Ask Your Doctor email series
may contain sponsored content.
18+, US residents only please.
Get the MOST from QualityHealth
- Top Searches
- 1. Arthritis Management: Nature Heals
- 2. 5 Digestive To-Dos
- 3. Men: Should You Shave It or Leave It?
- 4. Today's Top Fitness Trends
- 5. Sugar and Osteoarthritis : The Link
- 6. Can't Afford Your Hospital Bills?
- 7. Stay Energized All Day Long
- 8. Phobias: Who Has Them and Why?
- 9. What If Your EpiPen Fails?
- 10. 5 Costly Medical Billing Mistakes
- 1. Ice Falls Can Cause Serious Injuries
- 2. Can Inactivity Act Like a Disease?
- 3. Kale Snack Recipe for Diabetics
- 4. How Running Affects Arthritis
- 5. Sugar and Your Immunity System
- 6. Do Weight Loss Supplements Work?
- 7. 5 Super Foods for Spring
- 8. The Hazards of Reusable Bags
- 9. How to Avoid Ingrown Hairs
- 10. Health Tip: Constantly Change Shoes
- 1. 4 Common Treatments for Epilepsy
- 2. What Does a Urogynecologist Do?
- 3. GERD Without Heartburn? It's Possible
- 4. Graston Technique: Can It Work on You?
- 5. Music Therapy Can Help Autism
- 6. 8 Ways to Fight MS-Related Fatigue
- 7. Can You Still Bleed After Menopause?
- 8. Be Your Own Health Care Advocate
- 9. Why Is Syphillis on the Rise?
- 10. Ideal Weight vs. Happy Weight
The material on the QualityHealth Web site is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a physician or other qualified health provider. See additional information.